A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.
Jennifer A. Palmer, MS
Advertisement
Articles by Jennifer A. Palmer, MS
A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.
Advertisement
Latest Updated Articles
- Quality of Clinical and Economic Evidence in Dossier Formulary Submissions
Published: July 1st 2007 | Updated:
- A Strategic Plan for Integrating Cost-effectiveness Analysis Into the US Healthcare System
Published: April 15th 2008 | Updated:
- Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?
Published: September 7th 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
2
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
3
Contributor: Why Public Health Keeps Failing—and How to Fix It
4
Stool-Based DNA Testing Leads to Timely Colonoscopy in Rural, Urban Populations
5
